Rane Brake Linings Ltd
NSE:RBL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Rane Brake Linings Ltd
NSE:RBL
|
IN |
|
Z
|
Zealand Pharma A/S
OTC:ZLDPF
|
DK |
|
Adese Gayrimenkul Yatirim AS
IST:ADESE.E
|
TR |
|
C
|
CBI Co Ltd
KOSDAQ:013720
|
KR |
|
Alcoa Corp
NYSE:AA
|
US |
|
T
|
Transtema Group AB
STO:TRANS
|
SE |
|
New Peoples Bankshares Inc
OTC:NWPP
|
US |
|
A&D Holon Holdings Co Ltd
TSE:7745
|
JP |
|
Magillem Design Services SA
PAR:MLMGL
|
FR |
|
U
|
Unlimited Travel Group UTG AB (publ)
STO:UTG
|
SE |
|
Hoe Leong Corporation Ltd
SGX:H20
|
SG |
|
Distil PLC
LSE:DIS
|
UK |
|
G
|
Genting Singapore Ltd
OTC:GIGNY
|
SG |
|
N
|
NU E Power Corp
OTC:NUEPF
|
CA |
|
Helix Biopharma Corp
TSX:HBP
|
CA |
|
Broadmedia Corp
TSE:4347
|
JP |
Cash Flow Statement
Cash Flow Statement
Rane Brake Linings Ltd
| Mar-2020 | Sep-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||
| Net Income |
447
|
331
|
469
|
510
|
347
|
405
|
0
|
0
|
544
|
814
|
|
| Depreciation & Amortization |
263
|
260
|
244
|
227
|
214
|
206
|
200
|
206
|
218
|
233
|
|
| Other Non-Cash Items |
(26)
|
7
|
(39)
|
(20)
|
6
|
286
|
(58)
|
(353)
|
(11)
|
(2)
|
|
| Cash Taxes Paid |
88
|
74
|
129
|
187
|
97
|
74
|
134
|
137
|
118
|
120
|
|
| Cash Interest Paid |
0
|
0
|
3
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
|
| Change in Working Capital |
50
|
(123)
|
(209)
|
(542)
|
(454)
|
(632)
|
(95)
|
141
|
(459)
|
(398)
|
|
| Cash from Operating Activities |
734
N/A
|
474
-35%
|
466
-2%
|
174
-63%
|
113
-35%
|
264
+133%
|
493
+87%
|
473
-4%
|
293
-38%
|
449
+53%
|
|
| Investing Cash Flow | |||||||||||
| Capital Expenditures |
(381)
|
(306)
|
(120)
|
(175)
|
(180)
|
(239)
|
(260)
|
(282)
|
(318)
|
(283)
|
|
| Other Items |
28
|
25
|
15
|
11
|
(1)
|
89
|
(220)
|
(84)
|
192
|
8
|
|
| Cash from Investing Activities |
(353)
N/A
|
(281)
+20%
|
(105)
+62%
|
(164)
-55%
|
(181)
-11%
|
(151)
+17%
|
(480)
-219%
|
(366)
+24%
|
(127)
+65%
|
(275)
-117%
|
|
| Financing Cash Flow | |||||||||||
| Net Issuance of Common Stock |
0
|
0
|
(124)
|
(142)
|
(18)
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(2)
|
(3)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
22
|
|
| Cash Paid for Dividends |
(143)
|
(144)
|
(87)
|
(193)
|
(193)
|
(155)
|
(155)
|
(193)
|
(193)
|
(232)
|
|
| Other |
(0)
|
(0)
|
(28)
|
(32)
|
(4)
|
0
|
(1)
|
0
|
(0)
|
(1)
|
|
| Cash from Financing Activities |
(145)
N/A
|
(147)
-1%
|
(241)
-64%
|
(369)
-53%
|
(217)
+41%
|
(156)
+28%
|
(156)
0%
|
(195)
-25%
|
(195)
0%
|
(211)
-8%
|
|
| Change in Cash | |||||||||||
| Effect of Foreign Exchange Rates |
1
|
2
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
237
N/A
|
48
-80%
|
120
+150%
|
(359)
N/A
|
(285)
+21%
|
(42)
+85%
|
(143)
-237%
|
(88)
+38%
|
(29)
+67%
|
(36)
-25%
|
|
| Free Cash Flow | |||||||||||
| Free Cash Flow |
353
N/A
|
168
-52%
|
346
+106%
|
(0)
N/A
|
(67)
-16 600%
|
25
N/A
|
234
+832%
|
191
-19%
|
(26)
N/A
|
166
N/A
|
|